Online inquiry

IVTScrip™ mRNA-Anti-APP, R1450(Cap 1, Pseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ13598MR)

This product GTTS-WQ13598MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & Pseudo-UTP. It ecodes the monoclonal antibody that targets APP gene. The antibody can be applied in Alzheimer's disease (AD) research.

Specifications
Product type	mRNA
Modified bases	Pseudo-UTP
5' Cap	Cap 1
Species	Homo sapiens
RefSeq	NM_000484.4
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	351
UniProt ID	P05067

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-APP, R1450(Cap 1, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WQ13598MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ10565MR	IVTScrip™ mRNA-Anti-IL23A, LY3074828(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	LY3074828
GTTS-WQ8318MR	IVTScrip™ mRNA-Anti-TFRC, HN-66000(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	HN-66000
GTTS-WQ9737MR	IVTScrip™ mRNA-Anti-TFRC, JR-141(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	JR-141
GTTS-WQ3503MR	IVTScrip™ mRNA-Anti-APP, BAN-2401(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	BAN-2401
GTTS-WQ15627MR	IVTScrip™ mRNA-Anti-TNFRSF13C, VAY-736(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	VAY-736
GTTS-WQ5571MR	IVTScrip™ mRNA-Anti-CD33, CDP-771(Cap 0, Pseudo-UTP, 120 nt-poly(A))	mRNA	CDP-771
GTTS-WQ11836MR	IVTScrip™ mRNA-Anti-LAG3, MK-4280(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	MK-4280
GTTS-WQ4165MR	IVTScrip™ mRNA-Anti-LAG3, BI-754111(Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))	mRNA	BI-754111

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST